共 50 条
Novel gene mutation in maturity-onset diabetes of the young: A case report
被引:2
|作者:
Zhang, Na
[1
,3
]
Zhao, Hui
[2
]
Li, Cui
[1
]
Zhang, Feng-Zhi
[1
]
机构:
[1] Liaocheng Third Peoples Hosp, Dept Endocrinol, Liaocheng 252000, Shandong, Peoples R China
[2] Binzhou Cent Hosp, Dept Endocrinol, Binzhou 251700, Shandong, Peoples R China
[3] Liaocheng Third Peoples Hosp, Dept Endocrinol, 62 Weiyu Rd, Liaocheng 252000, Shandong, Peoples R China
关键词:
Maturity-onset diabetes of the young;
MODY7;
KLF11 gene mutation;
Precise treatment;
Case report;
DIAGNOSIS;
MODY;
D O I:
10.12998/wjcc.v11.i5.1099
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
BACKGROUNDMaturity-onset diabetes of the young (MODY) is the most common monogenic type of diabetes. Recently, 14 gene mutations have been found to be associated with MODY. In addition, the KLF11 gene mutation is the pathogenic gene of MODY7. To date, the clinical and functional characteristics of the novel KLF11 mutation c. G31A have not yet been reported.CASE SUMMARYWe report of a 30-year-old male patient with a one-year history of nonketosisprone diabetes and a 3-generation family history of diabetes. The patient was found to carry a KLF11 gene mutation. Therefore, the clinical data of family members were collected and investigated. A total of four members of the family were found to have heterozygous mutations in the KLF11 gene c. G31A, which resulted in a change in the corresponding amino acid p.D11N. Three patients had diabetes mellitus, and one patient had impaired glucose tolerance.CONCLUSIONThe heterozygous mutation of the KLF11 gene c.G31A (p. D11N) is a new mutation site of MODY7. Subsequently, the main treatment included dietary interventions and oral drugs.
引用
收藏
页码:1099 / 1105
页数:7
相关论文